Will we be able to edit our own genomes by 2050?
Will we be able to edit our own genomes by 2050?
Plus
23
Ṁ7562030
64%
chance
1D
1W
1M
ALL
Resolves YES if personal genome editing technologies are widely available to the public before Jan 1, 2050; resolves NO otherwise.
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Sort by:
@YoavTzfati both somatic and germline genome editing technologies will need to be publicly available by 2050 in order for this market to resolve YES
What is this?
What is Manifold?
Manifold is the world's largest social prediction market.
Get accurate real-time odds on politics, tech, sports, and more.
Win cash prizes for your predictions on our sweepstakes markets! Always free to play. No purchase necessary.
Are our predictions accurate?
Yes! Manifold is very well calibrated, with forecasts on average within 4 percentage points of the true probability. Our probabilities are created by users buying and selling shares of a market.
In the 2022 US midterm elections, we outperformed all other prediction market platforms and were in line with FiveThirtyEight’s performance. Many people who don't like trading still use Manifold to get reliable news.
How do I win cash prizes?
Manifold offers two market types: play money and sweepstakes.
All questions include a play money market which uses mana and can't be cashed out.
and can't be cashed out.Selected markets will have a sweepstakes toggle. These require sweepcash to participate and winners can withdraw sweepcash as a cash prize. You can filter for sweepstakes markets on the browse page.
to participate and winners can withdraw sweepcash as a cash prize. You can filter for sweepstakes markets on the browse page.Redeem your sweepcash won from markets at 1.00 → $1.00, minus a 5% fee.
Learn more.1.00Related questions
What is this?
What is Manifold?
Manifold is the world's largest social prediction market.
Get accurate real-time odds on politics, tech, sports, and more.
Win cash prizes for your predictions on our sweepstakes markets! Always free to play. No purchase necessary.
Are our predictions accurate?
Yes! Manifold is very well calibrated, with forecasts on average within 4 percentage points of the true probability. Our probabilities are created by users buying and selling shares of a market.
In the 2022 US midterm elections, we outperformed all other prediction market platforms and were in line with FiveThirtyEight’s performance. Many people who don't like trading still use Manifold to get reliable news.
How do I win cash prizes?
Manifold offers two market types: play money and sweepstakes.
All questions include a play money market which uses mana and can't be cashed out.
and can't be cashed out.Selected markets will have a sweepstakes toggle. These require sweepcash to participate and winners can withdraw sweepcash as a cash prize. You can filter for sweepstakes markets on the browse page.
to participate and winners can withdraw sweepcash as a cash prize. You can filter for sweepstakes markets on the browse page.Redeem your sweepcash won from markets at 1.00 → $1.00, minus a 5% fee.
Learn more.1.00Related questions
Will scientists confirm the reversal of ageing in humans through genetic editing or other technologies by the end 2045?
66% chance
Will there be an in-vivo gene therapy that edits multiple genes at once approved anywhere in the world before 2030?
52% chance
Will we be able to clone a human being from a live sample of their DNA by 2040?
38% chance
Will gene editing have cured at least one major disease by 2025?
95% chance
By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial?
18% chance
Will it be possible to sequence a full human genome for US$50 by 2026?
24% chance
Will there be a genetic engineering method capable of changing an adult's chromosomal sex by 2100?
51% chance
Will there be a credible (see details) announcement of human multiplex gene editing (≥5 genomic loci) pre 2026?
34% chance
Will whole genome synthesis be developed for eukaryotic organisms before 2040?
85% chance
Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?
78% chance